Select Medical Holdings CorporationSEM

Where SEM's Net Debt / EBITDA sits inside its own 10-year distribution, with the yearly high, low and average.

$16.51-0.02 (-0.12%)Previous close
NYSEHealthcare

SEM Net Debt / EBITDA: current value, 10-year range and year-by-year history

Net Debt / EBITDA History

Historically priceyAbove avgAround avgBelow avgHistorically cheap
SEM Net Debt / EBITDA historySEM Net Debt / EBITDA from Sep 2023 to Mar 2026: low 5.72, high 11.67, latest 5.72.5.256.978.6910.4212.14Sep 23Mar 24Sep 24Mar 25Sep 25Mar 26med 6.61

SEM Net Debt / EBITDA by year

Yearly range of SEM’s net debt / ebitda from 2016 to 2026. Over the full period it ranged from 3.7 to 11.7, averaging 6.3.

SEM Net Debt / EBITDA — yearly low, average, high and year-end values
YearLowAverageHighYear-end
20265.75.75.75.7
20256.98.911.76.9
20246.16.57.16.2
20236.36.87.56.3
20225.77.28.08.0
20213.74.34.94.9
20205.76.16.65.7
20196.26.56.76.2
20184.95.56.34.9
20175.05.66.05.0
20165.85.85.95.9

Get notified when SEM Net Debt / EBITDA crosses a threshold

Free — one alert setup, notifications by push, Telegram, or Discord.

How many years of operating earnings it would take to pay off the company's net debt. The most common leverage ratio — higher means more financial risk and less flexibility.

Formula(Total Debt − Cash) / EBITDA
Full guide
How to read this chart

Watch the trend more than the level. Declining ratio = deleveraging, growing financial flexibility. Rising ratio = increasing leverage, which constrains dividends, buybacks, and future investment.

Key caveats
  • Sector context is essential: 3× is aggressive for a consumer brand but normal for a regulated utility. Always compare to sector peers.
  • Large acquisitions spike the ratio temporarily — check whether the integration plan credibly drives paydown.
Pro — up to 30-year history

Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.